1. Home / 
  2. Heraeus Medical at a Glance / 
  3. Press & News / 
  4. MDR approval PALACOS Bone Cements with Gentamicin

PALACOS® Bone Cements with Gentamicin Receive MDR Approval


Heraeus Medical announces that the antibiotic containing PALACOS®bone cements have received MDR approval. These include PALACOS® R+G, PALACOS® MV+G, PALACOS® LV+G and PALACOS® fast R+G.

Receiving the certificate confirms the quality and safety of the products as well as the high production standards.

"We are pleased to continue to provide our customers with our high-quality, proven products, thereby ensuring the best possible patient care." said Nicole Petermann, President of Heraeus Medical.

"We are proud that the majority of our products have now been submitted to the Notified Body and expect to have all products approved under the MDR requirements in 2023."

PALACOS® R+G is the world's first antibiotic-containing bone cement in arthroplasty and a leader in clinical evidence.1 For more than 50 years, this bone cement stands for unique product quality that contributes to a higher quality of life for patients.

1 Pilz V, Hanstein T. A Literature Review of the Clinical Evidence Situation of Bone Cements. Research & Reviews: Journal of Medical and Health Sciences 2018; 7(1): 31–36.